MSFinals-4729

A 72-year-old man with ovarian cancer is currently taking morphine sulphate modified release (MST) tablets orally 30 mg twice a day. He is admitted under palliative care and his pain is not controlling well. Your consultant asked you to prescribe oral morphine for breakthrough pain.
What dose of Oramorph and frequency should you prescribed?